October 2007 NVAC Meeting Minutes
Dr. Freed asked when the IOM Committee would be convened. Ms. Baciu explained that the process usually takes about 1 month and that they are hoping to have their first meeting in early December. Dr. Gordon also mentioned that the Vaccine Development and Supply Subcommittee would discuss the possibility of their participation in the IOM process during their Subcommittee meeting. Dr. Gellin ended the discussion by mentioning that NVAC should consider how the input of the entire Committee could be achieved, rather than just the input of one representative from NVAC.
As there was no further discussion, the full Committee adjourned, and members broke into their assigned Subcommittee meetings, which constituted the remainder of the meeting for the day.
Day 2—October 23
Dr. Birkhead opened the second day of the meeting in Dr. Freed’s absence as he had to return to Michigan.
Agency, Department, Advisory Committee, and Liaison Reports
Advisory Committee on Immunization Practices (ACIP)/National Center for Immunization and Respiratory Diseases (NCIRD)—Dr. Anne Schuchat
Dr. Schuchat reported that more than 80 million doses of the influenza vaccine have been distributed and that distribution of flu vaccine is expected to be completed by the end of October.
In August, NCIRD launched a preteen vaccination campaign with new communications materials targeting ethnic and minority media. They also released the first teen module of the NIS for 13- to 17-year-olds.
Dr. Schuchat reminded the group that the ACIP meeting would be held on Wednesday and Thursday and that ACIP was expected to vote on five main issues:
Use of the live attenuated influenza vaccine (LAIV) in two- to four-year-old populations;
Clarification of the PCV schedule in children 24 to 59 months of age;
A change in the age indications for the meningococcal conjugate vaccine (MCV) in high-risk children between 2 and 10 years of age;
The childhood and adolescent immunization schedules; and
The immunization schedule for HIV-infected adults.
Dr. Schuchat addressed the cluster of measles cases associated with the International Little League World Series. The index case was a Japanese player, and to date, there have been seven confirmed cases. This case highlights the variety of places where a person can be exposed to vaccine-preventable diseases. The sibling of the index case was a household exposure. There was a first-generation case of measles in Texas in a corporate sponsor who attended the game. There were also two second-generation cases of measles in Texas among college students that were linked to the corporate sponsor. Finally, there were two cases of measles in Michigan, one in an airline passenger who was seated near the index case, and one in an airport worker who was exposed to the index case. Dr. Schuchat explained that an MMWR report is currently being developed on this cluster of measles cases. She also mentioned that Japan has now passed India as the source of the most measles cases in 2007.